Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aerobic training plus silymarin in men with type 2 diabetes
IRCT20200215046506N1Phase 3Completed
- Sponsor
- Islamic Azad University, Gachsaran Branch
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of silymarin in type 2 diabetes mellitus (T2DM), sponsored by Islamic Azad University, Gachsaran Branch. Primary endpoints: Change in glycemic indices and Change in liver enzymes. Started Jul 2019; status: completed.
02
Drugs
silymarin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT20200215046506N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200215046506N1.